Great interview, thanks Bpharma. After all this time with all the associated hiccups and hold ups I must admit I am still holding on and still believe this company has a massive future.Hoping for the day when they can actually sell a therapy commercially but more significantly sell a therapy that answers a huge unmet need.Just the simple idea that an infection caused by many possible different bacteria might be treated with this single compound rather than having to cross match for a specific anti biotic seems life saving.
Good luck to all holders, hopefully current deals can get this over the line.
Great interview, thanks Bpharma. After all this time with all...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
-0.015(2.46%) |
Mkt cap ! $121.3M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 62.5¢ | 59.5¢ | $102.7K | 169.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28498 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
61.5¢ |
Change
-0.015 ( 0.82 %) |
||||
| Open | High | Low | Volume | ||
| 62.0¢ | 63.0¢ | 59.5¢ | 82843 | ||
| Last updated 15.58pm 17/05/2024 ? | |||||
| RCE (ASX) Chart |